Search Results

Digital Supplement

Ushering in a New Treatment Paradigm for Glaucoma: Updates on Novel Therapeutics and Disease-Modifying Treatments

Nathan M. Radcliffe, MD; Earl Randy Craven, MD; Preeya K. Gupta, MD; and Robert N. Weinreb, MD

Fixed Combinations

A mainstay of glaucoma management today and tomorrow.

Robert D. Fetchner, MD, and Albert S. Khouri, MD

Fixed Combinations

A mainstay of glaucoma management today and tomorrow.

Robert D. Fetchner, MD, and Albert S. Khouri, MD

5 Questions With Robert D. Fechtner, MD

Dr. Fechtner makes a case for functional testing and divulges the secrets of brewing practically perfect espresso.

An Advance for Glaucoma Filtration

Robert D. Fechtner, MD

Is Trabeculectomy Still Our Best Surgical Option?

New devices are presenting interesting alternatives.

ROBERT D. FECHTNER, MD

Is Trabeculectomy Still Our Best Surgical Option?

New devices are presenting interesting alternatives.

ROBERT D. FECHTNER, MD

Therapeutics Update

Reducing the Preservative Load in Glaucoma Therapy

Improve the health of the ocular surface in patients taking IOP-lowering medications.

ROBERT D. FECHTNER, MD

Therapeutics Update

Reducing the Preservative Load in Glaucoma Therapy

Improve the health of the ocular surface in patients taking IOP-lowering medications.

ROBERT D. FECHTNER, MD

The “How”and the “Whom” of the EX-PRESS Device

Pearls for choosing the best candidates and surgical techniques for the EX-PRESS device.

ROBERT D. FECHTNER, MD

Ocular Surface Disease in the Presence of Glaucoma

The effect of topical IOP-lowering therapy on the ocular surface and considerations in the management of these comorbidities.

Therapeutics Update

Adherence and Fixed-Combination Agents

Evidence shows that patients benefit from a simple dosing regimen.

Robert D. Fechtner, MD

Therapeutics Update

Adherence and Fixed-Combination Agents

Evidence shows that patients benefit from a simple dosing regimen.

Robert D. Fechtner, MD

Interpreting Progression Analysis Software

Experts discuss the impact of the tools provided by advanced imaging systems on patient care.

Kyung Rim Sung, MD, Kelly A. Townsend, BS; Gadi Wollstein, MD; Hiroshi Ishikawa, MD; Joel S. Schuman, MD; and Robert D. Fechtner, MD

Interpreting Progression Analysis Software

Experts discuss the impact of the tools provided by advanced imaging systems on patient care.

Kyung Rim Sung, MD, Kelly A. Townsend, BS; Gadi Wollstein, MD; Hiroshi Ishikawa, MD; Joel S. Schuman, MD; and Robert D. Fechtner, MD

Interpreting Progression Analysis Software

Experts discuss the impact of the tools provided by advanced imaging systems on patient care.

Kyung Rim Sung, MD, Kelly A. Townsend, BS; Gadi Wollstein, MD; Hiroshi Ishikawa, MD; Joel S. Schuman, MD; and Robert D. Fechtner, MD

The Nerve Fiber Layer and Scanning Laser Polarimetry

The history and utility of this technology.

Robert D. Fechtner, MD

The Nerve Fiber Layer and Scanning Laser Polarimetry

The history and utility of this technology.

Robert D. Fechtner, MD

Target IOP for Advanced Glaucoma

Does everyone need an IOP of 12.3 mm Hg? Why would we even ask?

Robert D. Fechtner, MD

Target IOP for Advanced Glaucoma

Does everyone need an IOP of 12.3 mm Hg? Why would we even ask?

Robert D. Fechtner, MD